期刊
NATURE BIOTECHNOLOGY
卷 31, 期 9, 页码 827-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2647
关键词
-
资金
- National Institutes of Health (NIH) [R01-GM34277, R01-CA133404, R01-DK097768]
- NIH Nanomedicine Development Center [PN2EY018244]
- NIH Director's Pioneer Award [DP1-MH100706]
The Streptococcus pyogenes Cas9 (SpCas9) nuclease can be efficiently targeted to genomic loci by means of single-guide RNAs (sgRNAs) to enable genome editing(1-10). Here, we characterize SpCas9 targeting specificity in human cells to inform the selection of target sites and avoid off-target effects. Our study evaluates >700 guide RNA variants and SpCas9-induced indel mutation levels at >100 predicted genomic off-target loci in 293T and 293FT cells. We find that SpCas9 tolerates mismatches between guide RNA and target DNA at different positions in a sequence-dependent manner, sensitive to the number, position and distribution of mismatches. We also show that SpCas9-mediated cleavage is unaffected by DNA methylation and that the dosage of SpCas9 and sgRNA can be titrated to minimize off-target modification. To facilitate mammalian genome engineering applications, we provide a web-based software tool to guide the selection and validation of target sequences as well as off-target analyses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据